Divis Laboratories reports 12% rise in Q3 consolidated net profit

Divis Laboratories has reported results for third quarter ended December 31, 2015.  

The company has reported 11.78% rise in its net profit at Rs 246.56 crore for the quarter ended December 31, 2015 as compared to Rs 220.58 crore for the same quarter in the previous year. The company’s total income has increased by 7.03% to Rs 868.07 crore for the quarter under review from Rs 811.06 crore for the corresponding quarter of the previous year.  

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.